The Chemours Company Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: 4.84%

The Chemours Company Return on Equity (ROE) is 4.84% for the Trailing 12 Months (TTM) ending March 31, 2025, a -111.19% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • The Chemours Company Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was -43.25%, a -206.84% change year over year.
  • The Chemours Company Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 40.48%, a -43.87% change year over year.
  • The Chemours Company Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 72.12%, a 155.95% change year over year.
  • The Chemours Company Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was 28.18%, a -570.26% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share